{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:02:26Z","timestamp":1775685746895,"version":"3.50.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T00:00:00Z","timestamp":1455148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose.<\/jats:title>\n                  <jats:p>From a global perspective, the rates of allogeneic hematopoietic cell transplantation (alloHCT) are closely related to the economic status of a country. However, a potential association with outcome has not yet been documented. The goal of this study was to evaluate effects of health care expenditure (HCE), Human Development Index (HDI), team density, and center experience on nonrelapse mortality (NRM) after HLA-matched sibling alloHCT for adults with acute lymphoblastic leukemia (ALL).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and Methods.<\/jats:title>\n                  <jats:p>A total of 983 patients treated with myeloablative alloHCT between 2004 and 2008 in 24 European countries were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>In a univariate analysis, the probability of day 100 NRM was increased for countries with lower current HCE (8% vs. 3%; p = .06), countries with lower HDI (8% vs. 3%; p = .02), and centers with less experience (8% vs. 5%; p = .04). In addition, the overall NRM was increased for countries with lower current HCE (21% vs. 17%; p = .09) and HDI (21% vs. 16%; p = .03) and for centers with lower activity (21% vs. 16%; p = .07). In a multivariate analysis, the strongest predictive model for day 100 NRM included current HCE greater than the median (hazard ratio [HR], 0.39; p = .002). The overall NRM was mostly predicted by HDI greater than the median (HR, 0.65; p = .01). Both lower current HCE and HDI were associated with decreased probability of overall survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion.<\/jats:title>\n                  <jats:p>Both macroeconomic factors and the socioeconomic status of a country strongly influence NRM after alloHCT for adults with ALL. Our findings should be considered when clinical studies in the field of alloHCT are interpreted.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2015-0314","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T03:44:03Z","timestamp":1455248643000},"page":"377-383","source":"Crossref","is-referenced-by-count":11,"title":["Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT"],"prefix":"10.1093","volume":"21","author":[{"given":"Sebastian","family":"Giebel","sequence":"first","affiliation":[{"name":"a Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[{"name":"b Hospital Saint-Antoine, Asistance Publique Hopitaux de Paris, Paris, France"},{"name":"c European Group for Blood and Marrow Transplantation, Acute Leukemia Working Party Office, Hospital Saint Antoine, Paris, France"},{"name":"d Universite Pierre et Marie Curie, Paris, France"},{"name":"e INSERM Unit\u00e9s Mixtes de Recherche 938, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalberto","family":"Ibatici","sequence":"additional","affiliation":[{"name":"f Azienda Ospedaliera Universitaria San Martino Istituto di Ricovero e Cura a Carattere Scientifico, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Browne","sequence":"additional","affiliation":[{"name":"g St. James\u2019s Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Czerw","sequence":"additional","affiliation":[{"name":"a Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Socie","sequence":"additional","affiliation":[{"name":"h Hopital St. Louis, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Unal","sequence":"additional","affiliation":[{"name":"i Erciyes Medical School, Kapadokya Bone Marrow Transplanatation Center, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slawomira","family":"Kyrcz-Krzemien","sequence":"additional","affiliation":[{"name":"j Silesian Medical University, Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bacigalupo","sequence":"additional","affiliation":[{"name":"f Azienda Ospedaliera Universitaria San Martino Istituto di Ricovero e Cura a Carattere Scientifico, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Goker","sequence":"additional","affiliation":[{"name":"k Hacettepe University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Potter","sequence":"additional","affiliation":[{"name":"l Trustee of London Clinic, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline L.","family":"Furness","sequence":"additional","affiliation":[{"name":"l Trustee of London Clinic, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"McQuaker","sequence":"additional","affiliation":[{"name":"m Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"Beelen","sequence":"additional","affiliation":[{"name":"n University Hospital, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Milpied","sequence":"additional","affiliation":[{"name":"o University Hospital and University of Bordeaux, Pessac, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Campos","sequence":"additional","affiliation":[{"name":"p Instituto Portugu\u0119s de Oncologia do Porto, Porto, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Craddock","sequence":"additional","affiliation":[{"name":"q Queen Elizabeth Hospital, Birmingham, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[{"name":"c European Group for Blood and Marrow Transplantation, Acute Leukemia Working Party Office, Hospital Saint Antoine, Paris, France"},{"name":"r Chaim Sheba Medical Center, Tel-Hashomer, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[{"name":"b Hospital Saint-Antoine, Asistance Publique Hopitaux de Paris, Paris, France"},{"name":"c European Group for Blood and Marrow Transplantation, Acute Leukemia Working Party Office, Hospital Saint Antoine, Paris, France"},{"name":"d Universite Pierre et Marie Curie, Paris, France"},{"name":"e INSERM Unit\u00e9s Mixtes de Recherche 938, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,2,11]]},"reference":[{"key":"2021122703520918200_B1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"2021122703520918200_B2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(00)02137-1","article-title":"Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia","volume":"355","author":"Frassoni","year":"2000","journal-title":"Lancet"},{"key":"2021122703520918200_B3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/blood-2010-01-266478","article-title":"Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia","volume":"116","author":"Giebel","year":"2010","journal-title":"Blood"},{"key":"2021122703520918200_B4","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: A global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"key":"2021122703520918200_B5","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood.V79.10.2771.bloodjournal79102771","article-title":"Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?","volume":"79","author":"Horowitz","year":"1992","journal-title":"Blood"},{"key":"2021122703520918200_B6","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2004-10-3863","article-title":"Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States","volume":"105","author":"Loberiza","year":"2005","journal-title":"Blood"},{"key":"2021122703520918200_B7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bmt.1702681","article-title":"Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: Analysis of data from the Japan Society for Hematopoietic Cell Transplantation","volume":"26","author":"Matsuo","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"2021122703520918200_B8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/bmt.2012.131","article-title":"The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT","volume":"48","author":"Giebel","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2021122703520918200_B9","volume-title":"Human Development Report 2009","author":"United","year":"2012"},{"key":"2021122703520918200_B10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: New representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"2021122703520918200_B11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2021122703520918200_B12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1703641","article-title":"Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia","volume":"30","author":"Van Agthoven","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"2021122703520918200_B13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.tp.0000226171.43943.d3","article-title":"Costs of allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Svahn","year":"2006","journal-title":"Transplantation"},{"key":"2021122703520918200_B14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbmt.2009.01.011","article-title":"Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122703520918200_B15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bmt.1705733","article-title":"Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy","volume":"40","author":"Saito","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"2021122703520918200_B16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1590\/S1679-45082012000100017","article-title":"Predicting mortality and cost of hematopoietic stem-cell transplantation","volume":"10","author":"Kerbauy","year":"2012","journal-title":"Einstein (Sao Paulo)"},{"key":"2021122703520918200_B17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood-2012-05-426783","article-title":"Economics of hematopoietic cell transplantation","volume":"120","author":"Khera","year":"2012","journal-title":"Blood"},{"key":"2021122703520918200_B18","doi-asserted-by":"crossref","first-page":"e2014046","DOI":"10.4084\/mjhid.2014.046","article-title":"Cost of hematopoietic stem cell transplantation in India","volume":"6","author":"Sharma","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2021122703520918200_B19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bbmt.2014.05.011","article-title":"Financial burden in recipients of allogeneic hematopoietic cell transplantation","volume":"20","author":"Khera","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122703520918200_B20","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood-2013-06-506725","article-title":"Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission","volume":"122","author":"Walter","year":"2013","journal-title":"Blood"},{"key":"2021122703520918200_B21","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2010.30.4121","article-title":"Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation","volume":"29","author":"Gratwohl","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2015-0314","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2015-0314","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/21\/3\/377\/41927357\/oncolo_21_3_377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/21\/3\/377\/41927357\/oncolo_21_3_377.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T03:53:06Z","timestamp":1640577186000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/21\/3\/377\/6401341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,11]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,2,11]]},"published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2015-0314","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,3,1]]},"published":{"date-parts":[[2016,2,11]]}}}